Sevelamer Carbonate In vitro binding study for EMA submission [Regulatives / Guidelines]

posted by jansari – India, 2022-05-27 18:54 (40 d 23:49 ago) – Posting: # 23029
Views: 203

Dear divyen,

We have already gone through this PAR.bt the same it's just before published guidance..so regulatory not accept this PAR..

And it's very difficult to pass the study in this acceptance range..it's very stringent range for sevelamer carbonate..and guidance doesn't provide any methodology like USFDA..


If you have any idea and submit sevelamer study in europe Market then please guide....


Thank you very much for your prompt reply and guidance...

Complete thread:

UA Flag
Activity
 Admin contact
22,192 posts in 4,651 threads, 1,574 registered users;
online 6 (1 registered, 5 guests [including 3 identified bots]).
Forum time: Thursday 18:43 CEST (Europe/Vienna)

Any sufficiently advanced technology
is indistinguishable from magic.    Arthur C. Clarke

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5